Fig. 2
From: Depression risk among breast cancer survivors: a nationwide cohort study in South Korea
Cumulative incidence of depression according to treatment type. Overall (a), anthracycline (b), trastuzumab (c), anthracycline and trastuzumab (d), tamoxifen and aromatase inhibitor (e), radiation therapy (f)